Select the Industry/ Sector 👉    All Sectors

Top Healthcare Sector Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹25,725.8
₹54,666 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,895.9
₹36,180 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹524.5
₹8,255 Cr
Pharmaceuticals & Drugs
₹693.8
₹6,289 Cr
Pharmaceuticals & Drugs
₹299.1
₹3,348 Cr
Pharmaceuticals & Drugs
₹353.0
₹3,222 Cr
Pharmaceuticals & Drugs
₹84.7
₹2,174 Cr
Pharmaceuticals & Drugs
₹717.3
₹409 Cr
Pharmaceuticals & Drugs
₹71.7
₹203 Cr
Pharmaceuticals & Drugs
₹34.7
₹169 Cr

Top Healthcare Sector Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,895.9
₹5,202 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹524.5
₹4,257 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹353.0
₹2,522 Cr
Pharmaceuticals & Drugs
₹693.8
₹1,801 Cr
Pharmaceuticals & Drugs
₹299.1
₹710 Cr
Pharmaceuticals & Drugs
₹84.7
₹240 Cr
Pharmaceuticals & Drugs
₹34.7
₹129 Cr
Pharmaceuticals & Drugs
₹25,725.8
₹6,824 Cr
Pharmaceuticals & Drugs
₹717.3
₹323 Cr
Pharmaceuticals & Drugs
₹71.7
₹391 Cr

Top Healthcare Sector Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,895.9
₹1,015 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹524.5
₹325 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹693.8
₹211 Cr
Pharmaceuticals & Drugs
₹353.0
₹202 Cr
Pharmaceuticals & Drugs
₹299.1
₹155 Cr
Pharmaceuticals & Drugs
₹84.7
₹140 Cr
Pharmaceuticals & Drugs
₹34.7
₹5 Cr
Pharmaceuticals & Drugs
₹25,725.8
₹1,524 Cr
Pharmaceuticals & Drugs
₹717.3
₹10 Cr
Pharmaceuticals & Drugs
₹71.7
₹3 Cr

You may also like the below Video Courses